Related Experiment Video

Updated: Jun 25, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

PDLIM4, an actin binding protein, suppresses prostate cancer cell growth

Donkena Krishna Vanaja1, Michael E Grossmann, John C Cheville

  • 1Department of Urology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Cancer Investigation
|February 13, 2009
PubMed

Insights

PDLIM4 acts as a tumor suppressor in prostate cancer. Restoring PDLIM4 expression inhibits cancer cell growth, proliferation, and tumor development by interacting with F-actin.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell biology

Background:

  • Prostate cancer is a leading cause of mortality worldwide.
  • The molecular mechanisms underlying prostate cancer progression are not fully understood.
  • Identifying novel tumor suppressors is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the molecular function of PDLIM4 in prostate cancer.
  • To determine the role of PDLIM4 in prostate cancer cell proliferation and tumor growth.
  • To elucidate the interaction of PDLIM4 with cellular components.

Main Methods:

  • Quantitative analysis of PDLIM4 mRNA and protein expression in prostate cancer cell lines.
  • Assessment of cell growth, clonogenicity, and cell-cycle phase distribution upon PDLIM4 re-expression.
  • Investigation of PDLIM4 interaction with F-actin using biochemical assays.
  • Evaluation of tumor growth in xenograft models following PDLIM4 restoration.

Main Results:

  • PDLIM4 expression was significantly reduced in multiple prostate cancer cell lines.
  • Re-expression of PDLIM4 inhibited cell growth and clonogenicity, inducing G1 cell-cycle arrest.
  • PDLIM4 was shown to directly interact with F-actin.
  • Restoration of PDLIM4 expression reduced tumor growth in vivo xenografts.

Conclusions:

  • PDLIM4 functions as a tumor suppressor in prostate cancer.
  • PDLIM4 controls cell proliferation by associating with F-actin.
  • PDLIM4 represents a potential therapeutic target for prostate cancer treatment.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...